OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $121,100 Invested

2011

University of Massachusetts Boston

Maria Morabito, PhD

Inhibitors of Mdm2-dependent PSD-95 ubiquitination as therapeutics for Alzheimer's disease

  • Funding Amount: $121,100
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed